0 |
CNTL |
Controls |
NCH |
1 |
GBM |
Glioblastoma multiforme |
NCH |
2 |
GBM |
Glioblastoma multiforme |
NCH |
3 |
GBM |
Glioblastoma multiforme |
NCH |
4 |
GBM |
Glioblastoma multiforme |
NCH |
5 |
GBM |
Glioblastoma multiforme |
NCH |
6 |
GBM |
Glioblastoma multiforme |
NCH |
7 |
GBM |
Glioblastoma multiforme |
NCH |
8 |
GBM |
Glioblastoma multiforme |
NCH |
9 |
OV |
Ovarian serous cystadenocarcinoma |
NCH |
10 |
GBM |
Glioblastoma multiforme |
NCH |
11 |
OV |
Ovarian serous cystadenocarcinoma |
NCH |
12 |
OV |
Ovarian serous cystadenocarcinoma |
NCH |
13 |
OV |
Ovarian serous cystadenocarcinoma |
NCH |
14 |
OV |
Ovarian serous cystadenocarcinoma |
NCH |
15 |
OV |
Ovarian serous cystadenocarcinoma |
NCH |
16 |
GBM |
Glioblastoma multiforme |
NCH |
17 |
OV |
Ovarian serous cystadenocarcinoma |
NCH |
18 |
OV |
Ovarian serous cystadenocarcinoma |
NCH |
19 |
OV |
Ovarian serous cystadenocarcinoma |
NCH |
20 |
GBM |
Glioblastoma multiforme |
NCH |
21 |
OV |
Ovarian serous cystadenocarcinoma |
NCH |
22 |
OV |
Ovarian serous cystadenocarcinoma |
NCH |
23 |
LUSC |
Lung squamous cell carcinoma |
NCH |
24 |
OV |
Ovarian serous cystadenocarcinoma |
NCH |
25 |
LAML |
Acute Myeloid Leukemia |
WUSM |
26 |
GBM |
Glioblastoma multiforme |
NCH |
27 |
OV |
Ovarian serous cystadenocarcinoma |
NCH |
28 |
COAD |
Colon adenocarcinoma |
NCH |
29 |
COAD |
Colon adenocarcinoma |
NCH |
30 |
COAD |
Colon adenocarcinoma |
NCH |
31 |
LUSC |
Lung squamous cell carcinoma |
NCH |
32 |
KIRC |
Kidney renal clear cell carcinoma |
NCH |
33 |
COAD |
Colon adenocarcinoma |
NCH |
34 |
LUAD |
Lung adenocarcinoma |
WUSM |
35 |
COAD |
Colon adenocarcinoma |
NCH |
36 |
COAD |
Colon adenocarcinoma |
NCH |
37 |
LUAD |
Lung adenocarcinoma |
NCH |
38 |
GBM |
Glioblastoma multiforme |
NCH |
39 |
LUSC |
Lung squamous cell carcinoma |
NCH |
40 |
OV |
Ovarian serous cystadenocarcinoma |
NCH |
41 |
COAD |
Colon adenocarcinoma |
NCH |
42 |
READ |
Rectum adenocarcinoma |
NCH |
43 |
READ |
Rectum adenocarcinoma |
NCH |
44 |
OV |
Ovarian serous cystadenocarcinoma |
NCH |
45 |
COAD |
Colon adenocarcinoma |
NCH |
46 |
READ |
Rectum adenocarcinoma |
NCH |
47 |
BRCA |
Breast invasive carcinoma |
NCH |
48 |
STAD |
Stomach adenocarcinoma |
NCH |
49 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
50 |
KIRC |
Kidney renal clear cell carcinoma |
NCH |
51 |
KIRP |
Kidney renal papillary cell carcinoma |
NCH |
52 |
LUAD |
Lung adenocarcinoma |
NCH |
53 |
LUSC |
Lung squamous cell carcinoma |
NCH |
54 |
HNSC |
Head and Neck squamous cell carcinoma |
NCH |
55 |
LIHC |
Liver hepatocellular carcinoma |
NCH |
56 |
BRCA |
Breast invasive carcinoma |
NCH |
57 |
STAD |
Stomach adenocarcinoma |
NCH |
58 |
LUAD |
Lung adenocarcinoma |
NCH |
59 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
60 |
LUSC |
Lung squamous cell carcinoma |
NCH |
61 |
BRCA |
Breast invasive carcinoma |
NCH |
62 |
GBM |
Glioblastoma multiforme |
NCH |
63 |
KIRC |
Kidney renal clear cell carcinoma |
NCH |
64 |
KIRC |
Kidney renal clear cell carcinoma |
NCH |
65 |
KIRC |
Kidney renal clear cell carcinoma |
NCH |
66 |
COAD |
Colon adenocarcinoma |
NCH |
67 |
READ |
Rectum adenocarcinoma |
NCH |
68 |
KIRC |
Kidney renal clear cell carcinoma |
NCH |
69 |
KIRC |
Kidney renal clear cell carcinoma |
NCH |
70 |
KIRC |
Kidney renal clear cell carcinoma |
NCH |
71 |
KIRP |
Kidney renal papillary cell carcinoma |
NCH |
72 |
BRCA |
Breast invasive carcinoma |
NCH |
73 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
74 |
BRCA |
Breast invasive carcinoma |
NCH |
75 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
76 |
COAD |
Colon adenocarcinoma |
NCH |
77 |
LUSC |
Lung squamous cell carcinoma |
NCH |
78 |
LGG |
Brain Lower Grade Glioma |
NCH |
79 |
GBM |
Glioblastoma multiforme |
NCH |
80 |
BRCA |
Breast invasive carcinoma |
NCH |
81 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
82 |
KIRC |
Kidney renal clear cell carcinoma |
NCH |
83 |
HNSC |
Head and Neck squamous cell carcinoma |
NCH |
84 |
LUAD |
Lung adenocarcinoma |
NCH |
85 |
BRCA |
Breast invasive carcinoma |
NCH |
86 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
87 |
THCA |
Thyroid carcinoma |
NCH |
88 |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
89 |
COAD |
Colon adenocarcinoma |
NCH |
90 |
KIRC |
Kidney renal clear cell carcinoma |
NCH |
91 |
PRAD |
Prostate adenocarcinoma |
NCH |
92 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
93 |
BRCA |
Breast invasive carcinoma |
NCH |
94 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
95 |
STAD |
Stomach adenocarcinoma |
NCH |
96 |
BRCA |
Breast invasive carcinoma |
NCH |
97 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
98 |
COAD |
Colon adenocarcinoma |
NCH |
99 |
READ |
Rectum adenocarcinoma |
NCH |
100 |
LIHC |
Liver hepatocellular carcinoma |
NCH |
101 |
LUSC |
Lung squamous cell carcinoma |
NCH |
102 |
READ |
Rectum adenocarcinoma |
NCH |
103 |
BRCA |
Breast invasive carcinoma |
NCH |
104 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
105 |
KIRC |
Kidney renal clear cell carcinoma |
NCH |
106 |
PAAD |
Pancreatic adenocarcinoma |
NCH |
107 |
HNSC |
Head and Neck squamous cell carcinoma |
NCH |
108 |
PRAD |
Prostate adenocarcinoma |
NCH |
109 |
BRCA |
Breast invasive carcinoma |
NCH |
110 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
111 |
GBM |
Glioblastoma multiforme |
NCH |
112 |
LGG |
Brain Lower Grade Glioma |
NCH |
113 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
114 |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
115 |
THCA |
Thyroid carcinoma |
NCH |
116 |
COAD |
Colon adenocarcinoma |
NCH |
117 |
BRCA |
Breast invasive carcinoma |
NCH |
118 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
119 |
LUAD |
Lung adenocarcinoma |
NCH |
120 |
BRCA |
Breast invasive carcinoma |
NCH |
121 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
122 |
READ |
Rectum adenocarcinoma |
NCH |
123 |
COAD |
Colon adenocarcinoma |
NCH |
124 |
BRCA |
Breast invasive carcinoma |
NCH |
125 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
126 |
THCA |
Thyroid carcinoma |
NCH |
127 |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
128 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
129 |
STAD |
Stomach adenocarcinoma |
NCH |
130 |
GBM |
Glioblastoma multiforme |
NCH |
131 |
LIHC |
Liver hepatocellular carcinoma |
NCH |
132 |
COAD |
Colon adenocarcinoma |
NCH |
133 |
READ |
Rectum adenocarcinoma |
NCH |
134 |
PAAD |
Pancreatic adenocarcinoma |
NCH |
135 |
DLBC |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
NCH |
136 |
BRCA |
Breast invasive carcinoma |
NCH |
137 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
138 |
COAD |
Colon adenocarcinoma |
NCH |
139 |
READ |
Rectum adenocarcinoma |
NCH |
140 |
LUSC |
Lung squamous cell carcinoma |
NCH |
142 |
BRCA |
Breast invasive carcinoma |
NCH |
143 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
144 |
LUAD |
Lung adenocarcinoma |
NCH |
145 |
HNSC |
Head and Neck squamous cell carcinoma |
NCH |
146 |
LGG |
Brain Lower Grade Glioma |
NCH |
147 |
BRCA |
Breast invasive carcinoma |
NCH |
148 |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
149 |
THCA |
Thyroid carcinoma |
NCH |
150 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
151 |
HNSC |
Head and Neck squamous cell carcinoma |
NCH |
152 |
STAD |
Stomach adenocarcinoma |
NCH |
153 |
LIHC |
Liver hepatocellular carcinoma |
NCH |
154 |
COAD |
Colon adenocarcinoma |
NCH |
155 |
BRCA |
Breast invasive carcinoma |
NCH |
156 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
157 |
COAD |
Colon adenocarcinoma |
NCH |
158 |
READ |
Rectum adenocarcinoma |
NCH |
159 |
LUSC |
Lung squamous cell carcinoma |
NCH |
160 |
LUAD |
Lung adenocarcinoma |
NCH |
161 |
PRAD |
Prostate adenocarcinoma |
NCH |
162 |
KIRP |
Kidney renal papillary cell carcinoma |
NCH |
163 |
LGG |
Brain Lower Grade Glioma |
NCH |
164 |
HNSC |
Head and Neck squamous cell carcinoma |
NCH |
165 |
STAD |
Stomach adenocarcinoma |
NCH |
166 |
LUAD |
Lung adenocarcinoma |
NCH |
167 |
BRCA |
Breast invasive carcinoma |
NCH |
168 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
169 |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
170 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
171 |
THCA |
Thyroid carcinoma |
NCH |
172 |
COAD |
Colon adenocarcinoma |
NCH |
173 |
LIHC |
Liver hepatocellular carcinoma |
NCH |
174 |
GBM |
Glioblastoma multiforme |
NCH |
175 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
176 |
THCA |
Thyroid carcinoma |
NCH |
177 |
BRCA |
Breast invasive carcinoma |
NCH |
178 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
179 |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
180 |
SKCM |
Skin Cutaneous Melanoma |
NCH |
181 |
LUSC |
Lung squamous cell carcinoma |
NCH |
182 |
THCA |
Thyroid carcinoma |
NCH |
183 |
LUAD |
Lung adenocarcinoma |
NCH |
184 |
PRAD |
Prostate adenocarcinoma |
NCH |
185 |
BRCA |
Breast invasive carcinoma |
NCH |
186 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
187 |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
188 |
HNSC |
Head and Neck squamous cell carcinoma |
NCH |
189 |
LGG |
Brain Lower Grade Glioma |
NCH |
190 |
HNSC |
Head and Neck squamous cell carcinoma |
NCH |
191 |
THCA |
Thyroid carcinoma |
NCH |
192 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
193 |
LUSC |
Lung squamous cell carcinoma |
NCH |
194 |
KIRP |
Kidney renal papillary cell carcinoma |
NCH |
195 |
PAAD |
Pancreatic adenocarcinoma |
NCH |
196 |
LUAD |
Lung adenocarcinoma |
NCH |
197 |
THCA |
Thyroid carcinoma |
NCH |
198 |
SKCM |
Skin Cutaneous Melanoma |
NCH |
199 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
200 |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
201 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
202 |
BRCA |
Breast invasive carcinoma |
NCH |
203 |
LIHC |
Liver hepatocellular carcinoma |
NCH |
204 |
LUAD |
Lung adenocarcinoma |
NCH |
205 |
THCA |
Thyroid carcinoma |
NCH |
206 |
SKCM |
Skin Cutaneous Melanoma |
NCH |
207 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
208 |
LUSC |
Lung squamous cell carcinoma |
NCH |
209 |
KIRP |
Kidney renal papillary cell carcinoma |
NCH |
210 |
PAAD |
Pancreatic adenocarcinoma |
NCH |
211 |
STAD |
Stomach adenocarcinoma |
NCH |
212 |
DLBC |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
NCH |
213 |
LUAD |
Lung adenocarcinoma |
NCH |
214 |
LUSC |
Lung squamous cell carcinoma |
NCH |
215 |
HNSC |
Head and Neck squamous cell carcinoma |
NCH |
216 |
BRCA |
Breast invasive carcinoma |
NCH |
217 |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
218 |
SARC |
Sarcoma |
NCH |
219 |
LGG |
Brain Lower Grade Glioma |
NCH |
220 |
STAD |
Stomach adenocarcinoma |
NCH |
221 |
PRAD |
Prostate adenocarcinoma |
NCH |
222 |
LUAD |
Lung adenocarcinoma |
NCH |
223 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
224 |
THCA |
Thyroid carcinoma |
NCH |
225 |
LUSC |
Lung squamous cell carcinoma |
NCH |
226 |
KICH |
Kidney Chromophobe |
NCH |
227 |
BRCA |
Breast invasive carcinoma |
NCH |
228 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
229 |
SARC |
Sarcoma |
NCH |
230 |
THCA |
Thyroid carcinoma |
NCH |
231 |
LIHC |
Liver hepatocellular carcinoma |
NCH |
232 |
LUAD |
Lung adenocarcinoma |
NCH |
233 |
LUSC |
Lung squamous cell carcinoma |
NCH |
234 |
BRCA |
Breast invasive carcinoma |
NCH |
235 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
236 |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
237 |
THCA |
Thyroid carcinoma |
NCH |
238 |
LUAD |
Lung adenocarcinoma |
NCH |
239 |
BRCA |
Breast invasive carcinoma |
NCH |
240 |
SKCM |
Skin Cutaneous Melanoma |
NCH |
241 |
HNSC |
Head and Neck squamous cell carcinoma |
NCH |
242 |
STAD |
Stomach adenocarcinoma |
NCH |
243 |
LUSC |
Lung squamous cell carcinoma |
NCH |
244 |
PRAD |
Prostate adenocarcinoma |
NCH |
245 |
LGG |
Brain Lower Grade Glioma |
NCH |
246 |
KIRP |
Kidney renal papillary cell carcinoma |
NCH |
247 |
PAAD |
Pancreatic adenocarcinoma |
NCH |
248 |
DLBC |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
NCH |
249 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
250 |
THCA |
Thyroid carcinoma |
NCH |
251 |
KICH |
Kidney Chromophobe |
NCH |
252 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
253 |
THCA |
Thyroid carcinoma |
NCH |
254 |
ESCA |
Esophageal carcinoma |
NCH |
255 |
BRCA |
Breast invasive carcinoma |
NCH |
256 |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
257 |
STAD |
Stomach adenocarcinoma |
NCH |
258 |
LUAD |
Lung adenocarcinoma |
NCH |
259 |
LUSC |
Lung squamous cell carcinoma |
NCH |
260 |
HNSC |
Head and Neck squamous cell carcinoma |
NCH |
261 |
KIRP |
Kidney renal papillary cell carcinoma |
NCH |
262 |
SKCM |
Skin Cutaneous Melanoma |
NCH |
263 |
SARC |
Sarcoma |
NCH |
264 |
LUAD |
Lung adenocarcinoma |
NCH |
265 |
HNSC |
Head and Neck squamous cell carcinoma |
NCH |
266 |
KIRP |
Kidney renal papillary cell carcinoma |
NCH |
267 |
LUSC |
Lung squamous cell carcinoma |
NCH |
268 |
PRAD |
Prostate adenocarcinoma |
NCH |
269 |
STAD |
Stomach adenocarcinoma |
NCH |
270 |
THCA |
Thyroid carcinoma |
NCH |
271 |
BRCA |
Breast invasive carcinoma |
NCH |
272 |
ESCA |
Esophageal carcinoma |
NCH |
273 |
HNSC |
Head and Neck squamous cell carcinoma |
NCH |
274 |
KIRC |
Kidney renal clear cell carcinoma |
NCH |
275 |
LIHC |
Liver hepatocellular carcinoma |
NCH |
276 |
LUSC |
Lung squamous cell carcinoma |
NCH |
277 |
SKCM |
Skin Cutaneous Melanoma |
NCH |
278 |
LUAD |
Lung adenocarcinoma |
NCH |
279 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
280 |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
281 |
KIRP |
Kidney renal papillary cell carcinoma |
NCH |
282 |
LGG |
Brain Lower Grade Glioma |
NCH |
283 |
LUSC |
Lung squamous cell carcinoma |
NCH |
284 |
PAAD |
Pancreatic adenocarcinoma |
NCH |
285 |
PRAD |
Prostate adenocarcinoma |
NCH |
286 |
SARC |
Sarcoma |
NCH |
287 |
LIHC |
Liver hepatocellular carcinoma |
NCH |
288 |
BRCA |
Breast invasive carcinoma |
NCH |
289 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
290 |
SARC |
Sarcoma |
NCH |
291 |
SKCM |
Skin Cutaneous Melanoma |
NCH |
292 |
LGG |
Brain Lower Grade Glioma |
NCH |
293 |
LUSC |
Lung squamous cell carcinoma |
NCH |
294 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
295 |
LGG |
Brain Lower Grade Glioma |
NCH |
296 |
BRCA |
Breast invasive carcinoma |
NCH |
297 |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
298 |
ESCA |
Esophageal carcinoma |
NCH |
299 |
KIRP |
Kidney renal papillary cell carcinoma |
NCH |
300 |
COAD |
Colon adenocarcinoma |
NCH |
301 |
HNSC |
Head and Neck squamous cell carcinoma |
NCH |
302 |
UCS |
Uterine Carcinosarcoma |
NCH |
303 |
LIHC |
Liver hepatocellular carcinoma |
NCH |
304 |
ACC |
Adrenocortical carcinoma |
NCH |
305 |
BRCA |
Breast invasive carcinoma |
NCH |
306 |
LGG |
Brain Lower Grade Glioma |
NCH |
307 |
SARC |
Sarcoma |
NCH |
308 |
PRAD |
Prostate adenocarcinoma |
NCH |
309 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
310 |
SARC |
Sarcoma |
NCH |
311 |
HNSC |
Head and Neck squamous cell carcinoma |
NCH |
312 |
PRAD |
Prostate adenocarcinoma |
NCH |
313 |
ACC |
Adrenocortical carcinoma |
NCH |
314 |
LIHC |
Liver hepatocellular carcinoma |
NCH |
315 |
PRAD |
Prostate adenocarcinoma |
NCH |
316 |
SKCM |
Skin Cutaneous Melanoma |
NCH |
317 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
318 |
HNSC |
Head and Neck squamous cell carcinoma |
NCH |
319 |
LGG |
Brain Lower Grade Glioma |
NCH |
320 |
PRAD |
Prostate adenocarcinoma |
NCH |
321 |
STAD |
Stomach adenocarcinoma |
NCH |
322 |
BRCA |
Breast invasive carcinoma |
NCH |
323 |
ESCA |
Esophageal carcinoma |
NCH |
324 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
325 |
KIRP |
Kidney renal papillary cell carcinoma |
NCH |
326 |
DLBC |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
NCH |
327 |
LIHC |
Liver hepatocellular carcinoma |
NCH |
328 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
329 |
LGG |
Brain Lower Grade Glioma |
NCH |
330 |
PAAD |
Pancreatic adenocarcinoma |
NCH |
331 |
PRAD |
Prostate adenocarcinoma |
NCH |
332 |
SKCM |
Skin Cutaneous Melanoma |
NCH |
333 |
STAD |
Stomach adenocarcinoma |
NCH |
334 |
BRCA |
Breast invasive carcinoma |
NCH |
335 |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
336 |
SARC |
Sarcoma |
NCH |
337 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
338 |
BRCA |
Breast invasive carcinoma |
NCH |
339 |
ESCA |
Esophageal carcinoma |
NCH |
340 |
KIRC |
Kidney renal clear cell carcinoma |
NCH |
341 |
LIHC |
Liver hepatocellular carcinoma |
NCH |
342 |
SARC |
Sarcoma |
NCH |
343 |
STAD |
Stomach adenocarcinoma |
NCH |
344 |
KIRP |
Kidney renal papillary cell carcinoma |
NCH |
345 |
LIHC |
Liver hepatocellular carcinoma |
NCH |
346 |
GBM |
Glioblastoma multiforme |
NCH |
347 |
LGG |
Brain Lower Grade Glioma |
NCH |
348 |
PRAD |
Prostate adenocarcinoma |
NCH |
349 |
PAAD |
Pancreatic adenocarcinoma |
NCH |
350 |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
351 |
KICH |
Kidney Chromophobe |
NCH |
352 |
LGG |
Brain Lower Grade Glioma |
NCH |
353 |
MESO |
Mesothelioma |
NCH |
354 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
355 |
HNSC |
Head and Neck squamous cell carcinoma |
NCH |
356 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
357 |
PRAD |
Prostate adenocarcinoma |
NCH |
358 |
SKCM |
Skin Cutaneous Melanoma |
NCH |
359 |
STAD |
Stomach adenocarcinoma |
NCH |
360 |
BRCA |
Breast invasive carcinoma |
NCH |
361 |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
362 |
ESCA |
Esophageal carcinoma |
NCH |
363 |
SARC |
Sarcoma |
NCH |
364 |
KIRP |
Kidney renal papillary cell carcinoma |
NCH |
365 |
LIHC |
Liver hepatocellular carcinoma |
NCH |
366 |
PCPG |
Pheochromocytoma and Paraganglioma |
NCH |
367 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
368 |
LGG |
Brain Lower Grade Glioma |
NCH |
369 |
PAAD |
Pancreatic adenocarcinoma |
NCH |
370 |
PRAD |
Prostate adenocarcinoma |
NCH |
371 |
STAD |
Stomach adenocarcinoma |
NCH |
372 |
BRCA |
Breast invasive carcinoma |
NCH |
373 |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
374 |
ESCA |
Esophageal carcinoma |
NCH |
375 |
SARC |
Sarcoma |
NCH |
376 |
KIRP |
Kidney renal papillary cell carcinoma |
NCH |
377 |
LIHC |
Liver hepatocellular carcinoma |
NCH |
378 |
GBM |
Glioblastoma multiforme |
NCH |
379 |
BRCA |
Breast invasive carcinoma |
NCH |
380 |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
381 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
382 |
ESCA |
Esophageal carcinoma |
NCH |
383 |
SARC |
Sarcoma |
NCH |
384 |
LIHC |
Liver hepatocellular carcinoma |
NCH |
385 |
COAD |
Colon adenocarcinoma |
NCH |
386 |
KIRP |
Kidney renal papillary cell carcinoma |
NCH |
387 |
KIRC |
Kidney renal clear cell carcinoma |
NCH |
388 |
SKCM |
Skin Cutaneous Melanoma |
NCH |
389 |
PRAD |
Prostate adenocarcinoma |
NCH |
390 |
PAAD |
Pancreatic adenocarcinoma |
NCH |
391 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
392 |
PAAD |
Pancreatic adenocarcinoma |
NCH |
393 |
SKCM |
Skin Cutaneous Melanoma |
NCH |
394 |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
395 |
ESCA |
Esophageal carcinoma |
NCH |
396 |
SARC |
Sarcoma |
NCH |
397 |
DLBC |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
NCH |
398 |
KIRP |
Kidney renal papillary cell carcinoma |
NCH |
399 |
LIHC |
Liver hepatocellular carcinoma |
NCH |
401 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
402 |
GBM |
Glioblastoma multiforme |
NCH |
403 |
HNSC |
Head and Neck squamous cell carcinoma |
NCH |
404 |
KIRC |
Kidney renal clear cell carcinoma |
NCH |
405 |
LIHC |
Liver hepatocellular carcinoma |
NCH |
406 |
LUAD |
Lung adenocarcinoma |
NCH |
407 |
DLBC |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
NCH |
408 |
SKCM |
Skin Cutaneous Melanoma |
NCH |
409 |
OV |
Ovarian serous cystadenocarcinoma |
NCH |
410 |
PAAD |
Pancreatic adenocarcinoma |
NCH |
411 |
READ |
Rectum adenocarcinoma |
NCH |
412 |
SARC |
Sarcoma |
NCH |
413 |
STAD |
Stomach adenocarcinoma |
NCH |
414 |
THCA |
Thyroid carcinoma |
NCH |
415 |
LUSC |
Lung squamous cell carcinoma |
NCH |
416 |
SKCM |
Skin Cutaneous Melanoma |
NCH |
417 |
UVM |
Uveal Melanoma |
NCH |
418 |
MESO |
Mesothelioma |
NCH |
419 |
ESCA |
Esophageal carcinoma |
NCH |
420 |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
421 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
NCH |
422 |
COAD |
Colon adenocarcinoma |
NCH |
423 |
LUAD |
Lung adenocarcinoma |
NCH |
424 |
PAAD |
Pancreatic adenocarcinoma |
NCH |
425 |
LIHC |
Liver hepatocellular carcinoma |
NCH |
426 |
SARC |
Sarcoma |
NCH |
427 |
STAD |
Stomach adenocarcinoma |
NCH |
428 |
CHOL |
Cholangiocarcinoma |
NCH |
429 |
PRAD |
Prostate adenocarcinoma |
NCH |
430 |
TGCT |
Testicular Germ Cell Tumors |
NCH |
431 |
THYM |
Thymoma |
NCH |
432 |
KIRP |
Kidney renal papillary cell carcinoma |
NCH |
433 |
BLCA |
Bladder Urothelial Carcinoma |
NCH |
434 |
PAAD |
Pancreatic adenocarcinoma |
NCH |
448 |
CHOL |
Cholangiocarcinoma |
NCH |
458 |
LCML |
Chronic Myelogenous Leukemia |
NCH |